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Effects of Supplemental Fish Oil on Resting Metabolic Rate, Body
Composition, and Salivary Cortisol in Healthy Adults
Abstract

Background: To determine the effects of supplemental fish oil (FO) on resting metabolic rate (RMR), body
composition, and cortisol production in healthy adults.
Methods: A total of 44 men and women (34 ± 13y, mean+SD) participated in the study. All testing was
performed first thing in the morning following an overnight fast. Baseline measurements of RMR were
measured using indirect calorimetry using a facemask, and body composition was measured using air
displacement plethysmography. Saliva was collected via passive drool and analyzed for cortisol concentration
using ELISA. Following baseline testing, subjects were randomly assigned in a double blind manner to one of
two groups: 4 g/d of Safflower Oil (SO); or 4 g/d of FO supplying 1,600 mg/d eicosapentaenoic acid (EPA)
and 800 mg/d docosahexaenoic acid (DHA). All tests were repeated following 6 wk of treatment. Pre to post
differences were analyzed using a treatment X time repeated measures ANOVA, and correlations were
analyzed using Pearson’s r.
Results: Compared to the SO group, there was a significant increase in fat free mass following treatment with
FO (FO = +0.5 ± 0.5 kg, SO = -0.1 ± 1.2 kg, p = 0.03), a significant reduction in fat mass (FO = -0.5 ± 1.3 kg,
SO = +0.2 ± 1.2 kg, p = 0.04), and a tendency for a decrease in body fat percentage (FO = -0.4 ± 1.3% body
fat, SO = +0. 3 ± 1.5% body fat, p = 0.08). No significant differences were observed for body mass (FO = 0.0 ±
0.9 kg, SO = +0.2 ± 0.8 kg), RMR (FO = +17 ± 260 kcal, SO = -62 ± 184 kcal) or respiratory exchange ratio
(FO = -0.02 ± 0.09, SO = +0.02 ± 0.05). There was a tendency for salivary cortisol to decrease in the FO
group (FO = -0.064 ± 0.142 μg/dL, SO = +0.016 ± 0.272 μg/dL, p = 0.11). There was a significant correlation
in the FO group between change in cortisol and change in fat free mass (r = -0.504, p = 0.02) and fat mass (r =
0.661, p = 0.001).
Conclusion: 6 wk of supplementation with FO significantly increased lean mass and decreased fat mass.
These changes were significantly correlated with a reduction in salivary cortisol following FO treatment.
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Effects of supplemental fish oil on resting
metabolic rate, body composition, and salivary
cortisol in healthy adults
Eric E Noreen*, Michael J Sass, Megan L Crowe, Vanessa A Pabon, Josef Brandauer, Lindsay K Averill

Abstract
Background: To determine the effects of supplemental fish oil (FO) on resting metabolic rate (RMR), body
composition, and cortisol production in healthy adults.
Methods: A total of 44 men and women (34 ± 13y, mean+SD) participated in the study. All testing was performed first
thing in the morning following an overnight fast. Baseline measurements of RMR were measured using indirect
calorimetry using a facemask, and body composition was measured using air displacement plethysmography. Saliva
was collected via passive drool and analyzed for cortisol concentration using ELISA. Following baseline testing, subjects
were randomly assigned in a double blind manner to one of two groups: 4 g/d of Safflower Oil (SO); or 4 g/d of FO
supplying 1,600 mg/d eicosapentaenoic acid (EPA) and 800 mg/d docosahexaenoic acid (DHA). All tests were repeated
following 6 wk of treatment. Pre to post differences were analyzed using a treatment X time repeated measures
ANOVA, and correlations were analyzed using Pearson’s r.
Results: Compared to the SO group, there was a significant increase in fat free mass following treatment with FO
(FO = +0.5 ± 0.5 kg, SO = -0.1 ± 1.2 kg, p = 0.03), a significant reduction in fat mass (FO = -0.5 ± 1.3 kg, SO = +0.2
± 1.2 kg, p = 0.04), and a tendency for a decrease in body fat percentage (FO = -0.4 ± 1.3% body fat, SO = +0. 3 ±
1.5% body fat, p = 0.08). No significant differences were observed for body mass (FO = 0.0 ± 0.9 kg, SO = +0.2 ±
0.8 kg), RMR (FO = +17 ± 260 kcal, SO = -62 ± 184 kcal) or respiratory exchange ratio (FO = -0.02 ± 0.09, SO =
+0.02 ± 0.05). There was a tendency for salivary cortisol to decrease in the FO group (FO = -0.064 ± 0.142 μg/dL,
SO = +0.016 ± 0.272 μg/dL, p = 0.11). There was a significant correlation in the FO group between change in
cortisol and change in fat free mass (r = -0.504, p = 0.02) and fat mass (r = 0.661, p = 0.001).
Conclusion: 6 wk of supplementation with FO significantly increased lean mass and decreased fat mass. These
changes were significantly correlated with a reduction in salivary cortisol following FO treatment.

Background
It is generally believed that a high-fat diet is a contributing factor to excess body fat accumulation due to the
greater energy density of fat and the relative inability of
the body to increase fat oxidation in the presence of
over consumption of fats [1,2]. However, several rodent
studies have shown clearly that diets rich in omega 3
fatty acids, specifically eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), which are found in large
amounts in the oil from cold-water fish, lead to
* Correspondence: enoreen@gettysburg.edu
Department of Health Sciences, Gettysburg College, Gettysburg
Pennsylvania, USA

significantly lower total body fat stores vs diets rich in
other fatty acids [3-7]. The exact mechanism(s) responsible for this phenomenon are not completely understood, but there are several possible explanations. For
example, EPA and DHA are very effective at suppressing
lipogenic gene expression [8,9], thereby limiting the
synthesis of lipids. EPA and DHA have also been found
to increase the oxidation of lipids as a result of an
increase in carnitine acyltransferase I (CAT 1) activity
[10,11], which allows greater fatty acid transport across
the inner mitochondrial matrix via the carnitine-acylcarnitine translocase mechanism [12]. Additionally, EPA
can increase mitochondrial lipid oxidation indirectly by
inhibiting acetyl-CoA carboxylase [13], which is the
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enzyme that catalyzes the synthesis of malonyl CoA, and
is a potent inhibitor of CAT I [14]. Moreover, EPA and
DHA can also decrease the sensitivity of CAT I to malonyl CoA [11,15] which may allow a higher rate of lipid
oxidation across a variety of different metabolic states. It
is also possible that omega 3 fatty acids may influence
total body lipid accretion by increasing thermogenesis as
a result of increased activity of uncoupling proteins and
peroxisomes [16], and/or by increasing lean body mass
[3,5], which would indirectly increase thermogenesis.
Although there is some disagreement in the literature,
there appears to be a negative effect of the stress hormone cortisol on body composition [17,18]. The welldocumented association between Cushing’s disease and
obesity [19] clearly shows that conditions that significantly increase cortisol levels can increase fat accretion.
However, it is not known if treatments that lower cortisol levels can positively impact body composition. There
is limited evidence that fish oil supplementation can
reduce cortisol levels [20], which raises the possibility
that the consumption of fish oil could decrease body fat
% by decreasing cortisol levels. To date, no study has
examined the relationship between salivary cortisol and
body composition following treatment with fish oil.
Despite the mechanistic data and results in rodents,
very little is known about the effects of omega 3 fatty
acids on body composition and metabolic rate in
humans. In the first study using humans, Couet et al.
[21] found that when 6 g/d of visible dietary fat was
replaced with 6 g/d of fish oil for 3 wk, there was a significant increase in fat oxidation as measured by RER,
and a concomitant decrease in total body fat as measured by dual energy X-ray absorptiometry. There was
also an increase in the resting metabolic rate, but this
was no longer evident when the observed slight increase
in lean mass during the fish oil treatment was accounted
for, perhaps suggesting that fish oil may increase RMR
by increasing lean mass. More recently, Hill et al. [22]
found that supplementing the diet with fish oil significantly reduced fat mass compared to a control group
supplemented with sunflower oil. Similarly, Thorsdottir
et al. [23] found that including fish, or fish oil supplements, in a hypoenergetic diet resulted in greater weight
loss in young overweight men compared to a hypoenergetic diet that did not include fish or fish oil.
The aim of the present study was 1) to determine the
effects of supplemental fish oil on body composition
and resting metabolic rate in healthy adults, and 2) to
determine the effects of supplemental fish oil on morning salivary cortisol concentrations, and determine if
there is a relationship between changes in salivary cortisol concentrations and changes in body composition following fish oil treatment.
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Methods
Prior to all testing, approval for the study was obtained
from the institutional review board at Gettysburg College and written informed consent was obtained from
all subjects.
Healthy adults (18-55y) were recruited through flyers
posted at Gettysburg College and surrounding community. Individuals who ate fatty fish at least 3 times a
month, or were supplementing their diet with omega 3
fatty acids, or had a known metabolic or endocrine disorder were excluded. Subjects were healthy and active,
but not engaged in consistent, systematic exercise training. In total, 44 individuals volunteered to participate
(Table 1). Subjects were asked to maintain their current
diet and exercise practices throughout the study.
Experimental Protocol

Subjects reported to the laboratory first thing in the
morning following a 10-12 h overnight fast for RMR
determination using open circuit indirect calorimetry
(n = 26) and body composition assessment using air displacement via the Bod Pod® (n = 44). Following these
tests, a saliva sample was taken via passive drool and
later analyzed for cortisol content. Subjects were then
randomly assigned in a double blind manner to one of
two groups:
Safflower oil (SO): 4 g/d of safflower oil (Genuine
Health Corporation, Toronto, Ontario, CA) administered in 4 enteric-coated capsules (each capsule provided 1 g of cold pressed, high linoleic acid,
safflower oil).
Fish oil (FO): 4 g/d concentrated fish oil (o3mega
extra strength, Genuine Health Corporation, Toronto, Ontario, CA) administered in 4 enteric-coated
capsules (each capsule provided 400 mg EPA and
200 mg DHA).
Subjects took 2 capsules with breakfast and 2 capsules
with dinner for a 6 wk period. All testing was repeated
following 6 wk of supplementation.
Body Composition

Body composition was assessed by whole body densitometry using air displacement via the Bod Pod® (Life Measurements, Concord, CA). All testing was done in
accordance with the manufacturer’s instructions as
detailed elsewhere [24]. Briefly, subjects were tested wearing only tight fitting clothing (swimsuit or undergarments) and an acrylic swim cap. The subjects wore the
exact same clothing for all testing. Thoracic gas volume
was estimated for all subjects using a predictive equation
integral to the Bod Pod® software. The calculated value
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Table 1 Pre and Post values following 6 weeks of treatment with 4 g/d of safflower oil, or 4 g/d of fish oil
Safflower Oil
Pre

Post

Fish Oil
Post-Pre
Difference

Pre

Post

Post-Pre
Difference

Sex
Male (n)

8

6

Female (n)

14

16

35 ± 14y
(29;41)

33 ± 13y
(27;39)

Age (y)
Weight (kg)

71.1 ± 15.2
(64.7;77.5)

71.3 ± 15.3
(65.1;77.6)

0.2 ± 0.8
(-0.2;0.6)

71.3 ± 14.4
(65.1;77.6)

71.3 ± 13.7
(65.1;77.6)

0.0 ± 0.9
(-0.4;0.4)

Body Fat (%)

27.7 ± 10.6
(23.0;32.4)

28.0 ± 10.8
(23.2;32.8)

0.3 ± 1.5†
(-0.4;1.0)

30.5 ± 7.7
(26.7;32.5)

30.1 ± 7.6
(26.3;33.9)

-0.4 ± 1.3†
(-1.2;0.2)

Fat Mass (kg)

19.7 ± 9.7
(15.4;24.0)

19.9 ± 9.9
(15.5;24.3)

0.2 ± 1.2*
(-0.3;0.7)

22.3 ± 8.2
(18.3;25.7)

21.8 ± 7.6
(18.2;25.0)

-0.5 ± 1.3*
(-1.1;0.1)

Fat Free Mass (kg)

50.5 ± 11.9
(45.2;55.5)

50.4 ± 12.3
(45.0;55.8)

-0.1 ± 1.2**
(-0.6;0.4)

50.1 ± 11.7
(45.1;55.1)

50.6 ± 11.9
(45.5;55.6)

0.5 ± 0.5**
(0.3;0.8)

Salivary Cortisol (μg/dL)

0.305 ± 0.240
(0.212;0.399)

0.321 ± 0.311
(0.217;0.425)

0.016 ± 0.272
(-0.108;0.140)

0.270 ± 0.179
(0.179;0.361)

0.206 ± 0.131
(0.104;0.308)

-0.064 ± 0.142
(-0.127;-0.002)

RMR (24 h Kcal); n = 26

1290 ± 295
(1103;1477)

1228 ± 277
(1053;1400)

-62 ± 184
(-179;55)

1335 ± 213
(1200;1470)

1352 ± 323
(1147;1557)

17 ± 260
(-148;152)

0.809 ± 0.052
(0.776;0.842)

0.832 ± 0.41
(0.806;0.858)

0.023 ± 0.54
(-0.011;0.057)

0.841 ± 0.59
(0.804;0878)

0.822 ± 0.48
(0.791;0.853)

-0.019 ± 0.85
(-0.073;0.035)

RER; n = 26

Data are expressed as means ± SD (95% confidence interval). Data were analyzed using a treatment X time repeated measures ANOVA
* significant treatment X time interaction, p = 0.04
** significant treatment X time interaction, p = 0.03
† treatment X time interaction, p = 0.08

for body density was used in the Siri equation [25] to
estimate body composition. A complete body composition measurement was performed twice, and if the body
fat % was within 0.05% the two tests were averaged. If
the two tests were not within 0.05% agreement, a third
test was performed and the average of 3 complete trials
was used for all body composition variables. All testing
was completed first thing in the morning following a 10
h overnight fast (water intake was allowed).
Resting Metabolic Rate (n = 24)

For logistical reasons, metabolic testing was only performed on the first twelve subjects from each group (n =
24). Subjects refrained from caffeine consumption and vigorous exercise for 24 h prior to the resting metabolic rate
(RMR) test. The subjects kept a detailed record of their
food intake for the day prior to testing, and this was used
to duplicate the diet for the day prior to all subsequent
tests. Subjects transported themselves to the lab with the
provision that they did not walk more than 100 meters
total for their commute. Subjects rested in the supine position in a darkened room covered with a light blanket. A
rubber face mask was used to collect expired gases for
analysis via open circuit indirect calorimetry using a Medgraphics Ultima Cardio II breath-by-breath system that
was calibrated prior to each test according to manufacturers specifications. (Medical Graphics Corporation, St.

Paul, MN, USA). While the subjects rested quietly, data
were collected for 40 min. The final 20 min of data collected was averaged and 24 h energy expenditure was calculated using the thermal equivalent of O 2 consumed
based on a non-protein RQ table [26].
Salivary analysis

Subjects rinsed their mouth with water prior to all saliva
collections to minimize contamination of the samples.
Saliva was collected in a polypropylene vial via passive
drool through a short straw and stored at -80°C until
analysis. Prior to analysis, samples were thawed and centrifuged at 10,000 g for 20 minutes to remove mucins
and analyzed for cortisol concentration using a commercially available enzyme immunoassay kit (Salimetrics,
State College, PA, USA). Salivary cortisol is a sensitive
marker of activation the hypothalamus-pituitary-adrenal
system’s response to stress and correlates very well with
blood cortisol concentrations [27].
Statistical Analysis

Data were analyzed using the Statistical Package for the
Social Sciences version 13 (SPSS Inc., Chicago, IL). A
treatment by time, repeated measures ANOVA was
used to evaluate significant differences, and a standard
pearson’s r was used to evaluate correlations. For all
analysis, the alpha level was set at p ≤ 0.05.
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Results from the body composition testing are presented
in Table 1. There were no significant differences
observed for body mass between the treatments (SO =
0.2 ± 0.8 kg; FO = 0.0 ± 0.9 kg; p = 0.52). However,
there was a significant treatment by time interaction
observed for fat free mass which means the change in
fat free mass over time was significantly different
between the treatments (Figure 1: SO = -0.1 ± 1.2 kg;
FO = +0.5 ± 0.5 kg; p = 0.03). Similarly, there was a significant treatment by time interaction for fat mass as
well (Figure 1: SO = 0.2 ± 1.2 kg; FO = -0.5 ± 1.3 kg; p
= 0.04). Percent body fat also tended to change differently over time between the treatments (SO = 0.3 ±
1.5%; FO = -0.4 ± 1.3%; p = 0.08).

μg/dL; p = 0.11). However, when a repeated measures t
test was performed on the Pre and Post scores of each
group independently, the SO change was not significant
(p = 0.79), but the Post score was significantly lower than
the Pre score in the FO group (p = 0.04). It is very likely
that the reduced statistical power of the omnibus F used
in the repeated measures ANOVA resulted in a type II
error, and the reduction in salivary cortisol concentrations following fish oil supplementation is a real effect. In
support of this, the 95% confidence interval of the PrePost difference in salivary cortisol concentration for the
fish oil group (table 1) contains only negative values
(-0.127 to -0.002 μg/dL), whereas the 95% confidence
interval for the safflower oil group is centered around a
mean difference value of essentially zero (-0.108 to 0.14
μg/dL). Taken together, these additional statistics suggest
that the reduction in salivary cortisol concentration
observed in the fish oil group is a real effect.
The change in salivary cortisol concentration in the
FO group was significantly correlated with the change
in % body fat (r = 0.638, p = 0.001), the change in fat
free mass (r = -0.504, p = 0.02) as well as the change in
fat mass (r = 0.661, p = 0.001). No significant correlations were observed in the SO group between the
change in salivary cortisol concentration and the change
in % body fat (r = -0.321; p = 0.17), change in fat free
mass (r = 0.007; p = 0.98), or the change in fat mass
(r = -0.309; p = 0.19).

Salivary Cortisol Concentrations

Metabolic Data

There was a tendency for salivary cortisol concentrations
to change differently over time between the two treatments (SO = 0.016 ± 0.272 μg/dL; FO = -0.072 ± 0.142

No significant differences between groups were observed
over time for resting metabolic rate (SO = -62 ± 184
kcal, FO = 17 ± 260 kcal; p = 0.40), or for the respiratory exchange ratio (SO = 0.023 ± 0.54; FO = -0.019 ±
0.85, p = 0.16).

Results
A total of 47 individuals volunteered to participate in
this study. Two individuals withdrew from the study citing personal time conflicts, and one participant withdrew from the study as a result of a possible reaction to
the safflower oil capsules. In general, both treatments
were very well tolerated and no other side effects were
noted for either group. Of particular importance, the
enteric coating of the fish oil capsules prevented “fish
burps,” which are a common side effect often experienced with fish oil supplementation. A total of 44 subjects completed the study (Table 1).
Body Composition

Figure 1 Change in fat mass and fat free mass following 6 wk
of treatment with either 4 g/d of safflower oil (SO), or 4 g/d of
fish oil (FO). Data are means ± SEM. * significant treatment X
time interaction, p = 0.04. ** significant treatment X time
interaction, p = 0.03

Discussion
The results of this study showed that 6 weeks of supplemental fish oil significantly increased lean mass, and significantly reduced fat mass in healthy adults. This is in
agreement with Couet et al. [21], who observed a significant 0.88 kg reduction in fat mass, and a non-significant
0.20 kg increase in lean mass following 3 weeks of an
increased consumption of fish oil. In their study, they
added fish oil to the diet, but kept total fat and energy
constant between the treatments. In the present study,
the fish oil was added on top of an ad libitum diet, with
instructions given to the subjects to maintain their normal dietary patterns throughout the study. Similarly,
Hill et al [22] found a significant reduction in fat mass
following 12 weeks of supplementation with fish oil in
overweight subjects. They also observed an increase in
lean mass in the fish oil group, however, like the data
reported by Couet et al. [21], it did not reach
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significance. Thorsdottir et al. [23] recently found that
supplementation with fish oil, or inclusion of fish in an
energy-restricted diet resulted in significantly greater
weight loss in young men. Additionally, they found that
young men taking the fish oil supplements had a significantly greater reduction in waist circumference compared to the control group, or the group that increased
their dietary intake of fish.
Unlike the Couet et al. study [21], we did not observe
an increase in RMR, or a decrease in RER following fish
oil treatment. The failure to find an increase in RMR
following fish oil treatment is hard to explain given the
significant increase in lean mass observed in the present
study. Several studies have shown that lean mass is the
largest determinant of RMR [28-30], and decreasing
lean mass decreases RMR [31], while increasing lean
mass increases RMR [32]. Therefore, it would be
expected that the increase in lean mass would correspond to an increased RMR following fish oil treatment.
In the Couet et al. study [21], metabolic data were measured for 45 min following a 90 min rest period. This is
a longer time period than the 40 min used in the present study. However, it is doubtful that this methodological difference between the studies contributed to the
differing effects observed for RMR and RER values since
recent studies have shown that very short rest periods
(as little as 5 min) produce reproducible results that
correlate extremely well with RMR measures made over
much longer time periods [33,34]. It is also unlikely that
the use of a subset (n = 24) of the total subject population can explain the failure to observe any metabolic
changes since analysis of the 24 subjects found that they
responded similar to the entire group in regards to body
composition changes. It remains unclear why the
increased lean mass observed following fish oil treatment did not correspond to an increase in RMR.
Intuitively it would make sense that if fat mass was
reduced, but resting metabolic rate did not change following fish oil treatment, then the amount of calories
coming from the oxidation of fatty acids should be
increased. However, this was not the case in the present
study. Although there was an absolute reduction in the
RER following fish oil treatment (which would indicate
an increased oxidation of fatty acids), the difference was
not statistically significant. While it is possible that a
type II error was committed and the reduction in RER
was a real effect, it is also possible that the fish oil treatment increased fat oxidation at other times during the
day such as during exercise [35], or during the postprandial period [36].
A potential shortcoming of the present study was not
using dietary records to monitor the subjects’ intake
during the study. Although there are several potential
problems with the use of dietary records (for a review of
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inaccuracies with self-recorded diet records see [37]),
they would have provided us with some insight into the
dietary habits of the subjects during the study. It therefore remains a possibility that the fish oil supplements
resulted in the subjects changing their normal dietary
habits. Although increasing dietary fat does not generally cause a decrease in voluntary fat intake [38], it has
been shown that fish oil may reduce appetite [39],
which could have led to the subjects consuming less
total calories during the study. While a reduction in
volitional food intake would explain the observed reduction in fat mass following fish oil treatment, it does not
explain the increase in lean mass we observed.
Although other studies have observed a significant
[3,5], or insignificant [21,22], increase in lean mass following fish oil treatment, to date no study has determined the mechanism by which dietary fish oil causes
an increased accretion of lean mass. One possibility lies
in the well-documented ability of dietary omega 3 fatty
acids to reduce inflammatory cytokines [40], since
inflammatory cytokines have the ability to increase protein degradation mainly by activating the ATP-ubiquitin-dependent pathway [41-45]. It is possible then, that
dietary fish oil is simply decreasing the breakdown of
protein tissue caused by inflammatory cytokines, and
this results in an increased accretion of protein over
time.
An alternative possibility is that fish oil supplementation was able to increase lean mass by reducing cortisol
levels since it is well established that cortisol increases
protein catabolism [46-49]. The significant negative correlation (r = -0.504, p = 0.02) observed in the fish oil
group between the change in lean mass and the change
in salivary cortisol concentrations would support this
hypothesis. Although other studies have observed a
decrease in cortisol levels following fish oil consumption
[20], the exact mechanism(s) responsible are currently
unknown. However, it is possible that the reduction of
IL-6 as a result of fish oil consumption [50] is causing a
reduction in cortisol production since it has been shown
that IL-6 induces increases in cortisol levels [51,52]. It is
unclear whether it is the well-documented ability of fish
oil to reduce inflammatory cytokines, the reduction in
cortisol, or a combination of both, that resulted in the
increased lean mass observed in the present study following fish oil treatment. More work is needed to determine the mechanism(s) responsible for the accretion of
lean mass following fish oil consumption.
The role of cortisol in obesity is poorly understood.
Excessive cortisol levels, such as those observed in
patients with Cushing’s disease, results in substantial fat
mass gains - especially in the abdominal region [17,19].
However, there is disagreement between studies about
the relationship between values of cortisol that are
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within a normal physiological range, and obesity [18].
Nevertheless, several studies have shown an association
with higher levels of cortisol and fat mass [53-58]. In
the present study, there was a significant correlation
between the change in salivary cortisol and the change
in fat mass following fish oil treatment (r = 0.661, p =
0.001). Recent work by Purnell et al. [59] has shown
that a reduction in fat mass as a result of dieting does
not lower cortisol production, which would suggest that
the relationship observed in the present study between
salivary cortisol and fat mass was not simply a result of
the reduction in fat mass. However, further work is
needed to determine exactly how the reduction in cortisol levels may have influenced fat loss observed in the
FO group.
In conclusion, 6 weeks of supplemental fish oil significantly increased lean mass, and significantly reduced fat
mass in healthy adults. Given the short duration of this
study, it is unclear how these changes would impact
long-term body composition changes and more research
is needed to determine the impact of chronic fish oil
supplementation on long-term body composition. The
reduction in salivary cortisol following fish oil treatment
was significantly correlated with the increased fat free
mass and the decreased fat mass observed. To the best
of our knowledge, this is the first time that this association has been described in the literature. Since higher
salivary cortisol levels are associated with higher mortality rates [60], the reduction in salivary cortisol levels
observed in the present study following fish oil supplementation likely has significant implications beyond
positive changes in body composition.
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